Recursion Pharmaceuticals

(385) 269-0203
info@recursion.com

Description

Recursion Pharmaceuticals is a next-gen biopharma company combining experimental biology and automation with artificial intelligence to discover potential drugs for genetic disease, inflammation, immunology, and infectious disease.

Founders:

Blake Borgeson

Dean Li

Company Size:

201-500

TechBuzz Articles:

Recursion's IPO Generates $502 Million, Mark Tullis, April 2021

Buzzworthy Mentions:

Recursion Announces Partnerships with Roche and Genentech, December 10, 2021

Recursion Pharmaceuticals Files for a $100 Million IPO, March 26th, 2021

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Our mission is to shine a spotlight on all great things happening in the Utah technology/startup community and be a fair, independent voice for the Utah Tech Scene.

              Google News

All contents © 2022 IsoTalent Inc. All rights reserved.


Terms of Use and Privacy Policy

Newsletter - Sign up to receive TechBuzz News weekly